Polyphenol administration impairs T-cell proliferation by imprinting a distinct dendritic cell maturational profile.
Francesca Romana Delvecchio, Elisa Vadrucci, Elisabetta Cavalcanti, Stefania De Santis, Dale Kunde, Michele Vacca, Jay Myers, Frederick Allen, Giusy Bianco, Alex Y Huang, Vladia Monsurro, Angelo Santino, Marcello Chieppa
Index: Eur. J. Immunol. 45 , 2638-49, (2015)
Full Text: HTML
Abstract
Currently little is known as to how nutritionally derived compounds may affect dendritic cell (DC) maturation and potentially prevent inappropriate inflammatory responses that are characteristic of chronic inflammatory syndromes. Previous observations have demonstrated that two polyphenols quercetin and piperine delivered through reconstituted oil bodies (ROBs-QP) can influence DC maturation in response to LPS leading to a modulated inflammatory response. In the present study, we examined the molecular effects of ROBs-QP exposure on DC differentiation in mice and identified a unique molecular signature in response to LPS administration that potentially modulates DC maturation and activity in inflammatory conditions. Following LPS administration, ROBs-QP-exposed DCs expressed an altered molecular profile as compared with control DCs, including cytokine and chemokine production, chemokine receptor repertoire, and antigen presentation ability. In vivo ROBs-QP administration suppresses antigen-specific T-cell division in the draining lymph nodes resulting from a reduced ability to create stable immunological synapse. Our data demonstrate that polyphenols exposure can drive DCs toward a new anti-inflammatory molecular profile capable of dampening the inflammatory response, highlighting their potential as complementary nutritional approaches in the treatment of chronic inflammatory syndromes. © 2015 WILEY-VCH Verlag GmbH & Co. KGaA, Weinheim.
Related Compounds
Related Articles:
MHC class II presentation is controlled by the lysosomal small GTPase, Arl8b.
2015-03-01
[J. Immunol. 194(5) , 2079-88, (2015)]
2015-03-01
[Tissue Eng. Part A 21(5-6) , 948-59, (2015)]
2015-03-01
[J. Neurooncol. 122(1) , 21-33, (2015)]
2014-08-15
[J. Immunol. 193(4) , 1717-27, (2014)]
2015-02-01
[J. Clin. Invest. 125(2) , 752-68, (2015)]